Delivery Order 75N95019D00026-75N95019F00089
Award Date
9/27/19
Potential Completion Date
9/25/24
Potential Value
$1.8M
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Psychogenics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Paramus, NJ 07652, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Psychogenics Inc., doing business as Psychogenics Inc., has been awarded a $45.9 million delivery order contract by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide screening of investigational agents through the Preclinical Screening Platform for Pain. The cost plus fixed fee contract will be performed over a five year period in Paramus, New Jersey. Under the contract, Psychogenics will screen investigational pain treatment agents through...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PGI Holding Corporation, a for-profit subchapter S corporation, to evaluate the efficacy of a nanoparticle formulation containing the drug aprepitant in a rodent model of neuropathic pain. The contract, valued at $216,900.00, has a period of performance from September 20, 2021 to March 31,...
This is a $3,893,053.00 cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit organization. The contract is for the characterization of a non-addictive small molecule therapeutic for the management of non-cancer pain, with a period of performance from September 18, 2020 to September 17, 2022, and an ultimate completion date of April 28, 2025....
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
<p>The National Institute of Neurological Disorders and Stroke, a civilian federal agency, awarded a $10,000.00 firm fixed price purchase order to Cranberry Lake Consulting Group LLC, a minority-owned and small disadvantaged business, for pharmacology consultation services with pain expertise on an Executive Oversight Committee (EOC) board. The contract has an ultimate completion date of July 1, 2025 and was awarded on July 2, 2024. No set-aside was used for this contract.</p>
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Southern Research Institute, a non-profit organization. The $1,593,565.26 contract is under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract is for the 28-day oral toxicity study in monkeys with a 33-day recovery period. Southern Research Institute has subcontracted a...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446.64 firm fixed price purchase order to Eurofins Discoverx Corporation of Fremont, California. The purchase order is for GPCRMAX PANEL services and will be performed between June 26, 2023 and September 30, 2023 in Fremont. The National Institute of Neurological Disorders and Stroke supports research on brain and nervous system disorders to reduce...
<p>The National Institute of Neurological Disorders and Stroke, a civilian federal agency, awarded a $10,000.00 firm fixed price purchase order for pharmacology consultation services to Michael Gavin Palfreyman, a for-profit organization, on July 2, 2024. The contract has an ultimate completion date of July 1, 2025 and was not set aside for a specific business classification. This contract award is not associated with a larger contract vehicle.</p>
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...